CTEV
CTEVHealthcareNASDAQHealth Information Services · Last scanned Sep 9, 2026
Scan Results
Daily timeframeOperating under the Health Information Services umbrella, CTEV is a healthcare company. Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in. The company carries a $639.1M market cap, placing it firmly in the small-cap category. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services.
Market Cap
$639.1M
Beta
0.89
P/E (TTM)
—
P/E (Fwd)
5.14
EPS (TTM)
$-17.00
EPS (Fwd)
$7.33
ROE
—
ROA
1.2%
Cash
$14.4M
Total Debt
$4.69B
Free CF
$103.0M
52W Change
-39.2%
Annual Financials
Cash vs Debt
Where CTEV stands vs its 150-day and 200-day moving averages
As of the August 24, 2026 close, CTEV finished 51.57% above its 150-day moving average ($24.59) and 27.94% above its 200-day moving average ($29.13). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is CTEV overbought or oversold?
At the August 24, 2026 close, CTEV's RSI(14) was 71.4, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, CTEV has $14.4M in cash with $4.69B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Free cash flow comes in at $103.0M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROA of 1.2% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $1.08B (2022) to $965.4M (2025), a 11% decline worth watching.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence CTEV's trajectory.